Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IIB
117TH CONGRESS
1ST SESSION H. R. 3146
IN THE SENATE OF THE UNITED STATES
MAY 19, 2021
Received; read twice and referred to the Committee on Banking, Housing, and
Urban Affairs
AN ACT
To amend the Defense Production Act of 1950 to ensure
the supply of certain medical materials essential to na-
tional defense, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
2
HR 3146 RFS
SECTION 1. SHORT TITLE.
1
This Act may be cited as the ‘‘Securing America’s
2
Vaccines for Emergencies Act of 2021’’ or the ‘‘SAVE Act
3
of 2021’’.
4
SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS.
5
(a) STATEMENT OF POLICY.—Section 2(b) of the De-
6
fense Production Act of 1950 (50 U.S.C. 4502) is amend-
7
ed—
8
(1) by redesignating paragraphs (3) through
9
(8) as paragraphs (4) through (9), respectively; and
10
(2) by inserting after paragraph (2) the fol-
11
lowing:
12
‘‘(3) authorities under this Act should be used
13
when appropriate to ensure the availability of med-
14
ical materials essential to national defense, including
15
through measures designed to secure the drug sup-
16
ply chain, and taking into consideration the impor-
17
tance of United States competitiveness, scientific
18
leadership and cooperation, and innovative capac-
19
ity;’’.
20
(b) STRENGTHENING DOMESTIC CAPABILITY.—Sec-
21
tion 107 of the Defense Production Act of 1950 (50
22
U.S.C. 4517) is amended—
23
(1) in subsection (a), by inserting ‘‘(including
24
medical materials)’’ after ‘‘materials’’; and
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
3
HR 3146 RFS
(2) in subsection (b)(1), by inserting ‘‘(includ-
1
ing medical materials such as drugs, devices, and bi-
2
ological products to diagnose, cure, mitigate, treat,
3
or prevent disease that are essential to national de-
4
fense)’’ after ‘‘essential materials’’.
5
(c) STRATEGY ON SECURING SUPPLY CHAINS FOR
6
MEDICAL MATERIALS.—Title I of the Defense Production
7
Act of 1950 (50 U.S.C. 4511 et seq.) is amended by add-
8
ing at the end the following:
9
‘‘SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR
10
MEDICAL MATERIALS.
11
‘‘(a) IN GENERAL.—Not later than 180 days after
12
the date of the enactment of this section, the President,
13
in consultation with the Secretary of Health and Human
14
Services, the Secretary of Commerce, the Secretary of
15
Homeland Security, and the Secretary of Defense, shall
16
transmit a strategy to the appropriate Members of Con-
17
gress that includes the following:
18
‘‘(1) A detailed plan to use the authorities
19
under this title and title III, or any other provision
20
of law, to ensure the supply of medical materials (in-
21
cluding drugs, devices, and biological products (as
22
that term is defined in section 351 of the Public
23
Health Service Act (42 U.S.C. 262)) to diagnose,
24
cure, mitigate, treat, or prevent disease) essential to
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
4
HR 3146 RFS
national defense, to the extent necessary for the pur-
1
poses of this Act.
2
‘‘(2) An analysis of vulnerabilities to existing
3
supply chains for such medical materials, and rec-
4
ommendations to address the vulnerabilities.
5
‘‘(3) Measures to be undertaken by the Presi-
6
dent to diversify such supply chains, as appropriate
7
and as required for national defense.
8
‘‘(4) A discussion of—
9
‘‘(A) any significant effects resulting from
10
the plan and measures described in this sub-
11
section on the production, cost, or distribution
12
of biological products (as that term is defined
13
in section 351 of the Public Health Service Act
14
(42 U.S.C. 262)) or any other devices or drugs
15
(as defined under the Federal Food, Drug, and
16
Cosmetic Act (21 U.S.C. 301 et seq.));
17
‘‘(B) a timeline to ensure that essential
18
components of the supply chain for medical ma-
19
terials are not under the exclusive control of a
20
foreign government in a manner that the Presi-
21
dent determines could threaten the national de-
22
fense of the United States; and
23
‘‘(C) efforts to mitigate any risks resulting
24
from the plan and measures described in this
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
5
HR 3146 RFS
subsection to United States competitiveness,
1
scientific leadership, and innovative capacity,
2
including efforts to cooperate and proactively
3
engage with United States allies.
4
‘‘(b) PROGRESS REPORT.—Following submission of
5
the strategy under subsection (a), the President shall sub-
6
mit to the appropriate Members of Congress an annual
7
progress report until September 30, 2025, evaluating the
8
implementation of the strategy, and may include updates
9
to the strategy as appropriate. The strategy and progress
10
reports shall be submitted in unclassified form but may
11
contain a classified annex.
12
‘‘(c) APPROPRIATE MEMBERS OF CONGRESS.—The
13
term ‘appropriate Members of Congress’ means the
14
Speaker, majority leader, and minority leader of the
15
House of Representatives, the majority leader and minor-
16
ity leader of the Senate, the Chairman and Ranking Mem-
17
ber of the Committee on Financial Services of the House
18
of Representatives, and the Chairman and Ranking Mem-
19
ber of the Committee on Banking, Housing, and Urban
20
Affairs of the Senate.’’.
21
SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY.
22
(a) IN GENERAL.—Section 303 of the Defense Pro-
23
duction Act of 1950 (50 U.S.C. 4533) is amended by add-
24
ing at the end the following:
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
6
HR 3146 RFS
‘‘(h) INVESTMENT IN SUPPLY CHAIN SECURITY.—
1
‘‘(1) IN GENERAL.—In addition to other au-
2
thorities in this title, the President may make avail-
3
able to an eligible entity described in paragraph (2)
4
payments to increase the security of supply chains
5
and supply chain activities, if the President certifies
6
to Congress not less than 30 days before making
7
such a payment that the payment is critical to meet
8
national defense requirements of the United States.
9
‘‘(2) ELIGIBLE ENTITY.—An eligible entity de-
10
scribed in this paragraph is an entity that—
11
‘‘(A) is organized under the laws of the
12
United States or any jurisdiction within the
13
United States; and
14
‘‘(B) produces—
15
‘‘(i) one or more critical components;
16
‘‘(ii) critical technology; or
17
‘‘(iii) one or more products or raw
18
materials for the security of supply chains
19
or supply chain activities.
20
‘‘(3) DEFINITIONS.—In this subsection, the
21
terms ‘supply chain’ and ‘supply chain activities’
22
have the meanings given those terms by the Presi-
23
dent by regulation.’’.
24
(b) REGULATIONS.—
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
7
HR 3146 RFS
(1) IN GENERAL.—Not later than 90 days after
1
the date of the enactment of this Act, the President
2
shall prescribe regulations setting forth definitions
3
for the terms ‘‘supply chain’’ and ‘‘supply chain ac-
4
tivities’’ for the purposes of section 303(h) of the
5
Defense Production Act of 1950 (50 U.S.C.
6
4533(h)), as added by subsection (a).
7
(2) SCOPE OF DEFINITIONS.—The definitions
8
required by paragraph (1)—
9
(A) shall encompass—
10
(i) the organization, people, activities,
11
information, and resources involved in the
12
delivery and operation of a product or serv-
13
ice used by the Government; or
14
(ii) critical infrastructure as defined
15
in Presidential Policy Directive 21 (Feb-
16
ruary 12, 2013; relating to critical infra-
17
structure security and resilience); and
18
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
8
HR 3146 RFS
(B) may include variations as determined
1
necessary and appropriate by the President for
2
purposes of national defense.
3
Passed the House of Representatives May 18, 2021.
Attest:
CHERYL L. JOHNSON,
Clerk.
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3146.RFS
H3146
kjohnson on DSK79L0C42PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.